MedBodh Clinical Drug Preparation | Updated 4 November 2026. Professional reference; verify local brand-specific prescribing information and hospital protocol before bedside administration.
CLINICAL SAFETY NOTICE (5 Nov 2026): Educational overview only, not a validated bedside preparation chart. Verify exact dose, dilution, rate, compatibility, stability, renal/hepatic adjustments and paediatric use against the specific product label, current institutional protocol and pharmacist. Do not infer dosing from this page alone.
Clinical indications and strengths
Anaphylaxis is treated with prompt intramuscular adrenaline into the mid-outer thigh; a labelled 1 mg/mL preparation is distinct from a resuscitation syringe or a diluted infusion. The cited manufacturer label describes 1 mg/mL vials and dilution of infusion concentrate in 5% dextrose or dextrose/saline. Never give a 1 mg/mL vial as an undiluted routine IV bolus. IV infusions require an infusion pump, defined concentration, continuous ECG and blood-pressure monitoring and trained staff.
Preparation and administration workflow
- Verify patient identity, indication, allergy history, body weight where applicable and prescriber’s order.
- Read actual vial/bag concentration and distinguish salt strength from active-base equivalent where relevant.
- Check manufacturer-authorised diluent, final concentration, compatibility, route, infusion pump and beyond-use time.
- Perform independent high-alert medication double-check and label every prepared syringe/bag.
- Document preparation, administration, monitoring and any adverse reaction.
Emergency safety, nursing monitoring and special populations
Indications: anaphylaxis and, by specialist protocol, shock. Adult and paediatric dosing must be selected by indication, weight and route; cardiac-arrest algorithms are separate. Check ampoule label, route, concentration and syringe twice. Watch for tachyarrhythmia, hypertension, myocardial ischaemia and extravasation. In pregnancy with anaphylaxis, timely treatment remains critical. In renal/hepatic disease titrate to clinical response under monitoring.
Adult and paediatric dosing
There is no single safe universal dose: dosing varies by indication, age/weight, organ function, formulation and clinical response. Use the linked full product label and the current hospital emergency algorithm rather than extrapolating one preparation to every scenario.
Contraindications, interactions and common errors
Review the product-specific label, comorbidities, concurrent medicines and IV compatibility. Do not mix drugs in the same line without verified compatibility. Escalate immediately for suspected medication error or adverse drug reaction.
Primary manufacturer label
DailyMed: current official product labelling. Indian brands can differ in concentration, excipients and authorised routes; verify the locally stocked ampoule.